Home › Trials › NCT06926153

Intervention to help reduce smoking in people with mental disorders

Evaluation of an Intervention to Reduce Smoking Among Mental Health Users Treated in Ambulatory Psychiatry

Not applicable Interventional Gcs-Ccoms · NCT06926153

This study tests a new program called 'Tabapsy' to see if it can help adults with mental disorders quit smoking while they receive outpatient psychiatric care.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment6500 (estimated)
Ages18 Years and up
SexAll
SponsorGcs-Ccoms Academic / other
Locations22 sites (Armentières and 21 other locations)
Trial IDNCT06926153 on ClinicalTrials.gov

What this trial studies

This study evaluates an intervention called 'Tabapsy' designed to support smoking cessation among adults with mental disorders receiving outpatient psychiatric care. The intervention was developed collaboratively with mental health service users, professionals, and general practitioners to address the high smoking rates in this population. It includes a promotional campaign within mental health centers to encourage smoking cessation and provide necessary support. The study aims to assess the effectiveness of this tailored approach in helping participants quit smoking.

Who should consider this trial

Good fit: Ideal candidates for this study are adults aged 18 and older who are regular smokers and receiving outpatient psychiatric care.

Not a fit: Patients who are under guardianship or legal protection, or those with a psychological state incompatible with completing the study questionnaire, may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the health and life expectancy of individuals with mental disorders by reducing smoking-related diseases.

How similar studies have performed: While smoking cessation interventions in psychiatric populations have been explored, this specific approach is novel and tailored to the unique needs of individuals with mental disorders.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Regular smokers (at least one cigarette per day)
* Followed in psychiatric ambulatory care at one of the participating sectors' CMPs
* Adults (18 years or older)
* Covered by the statuary health insurance
* Who gave their informed consent to participate to the study

Exclusion Criteria:

* Users under guardianship or legal protection,
* Psychological state incompatible with completing the questionnaire,
* Persons with no command or understanding of the French language

Where this trial is running

Armentières and 21 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Tobacco AddictionSmoking reductionPeople with mental disordersPsychiatry
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.